Literature DB >> 8227364

Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.

J Pfeilschifter1, C Schalkwijk, V A Briner, H van den Bosch.   

Abstract

Potent pro-inflammatory cytokines, such as interleukin 1 (IL-1) or tumor necrosis factor (TNF) alpha have been found to increase group II phospholipase A2 (PLA2) synthesis and secretion by mesangial cells. In all cases 85-90% of the enzyme is secreted from the cells and a parallel increase in prostaglandin (PG)E2 synthesis is observed. We report here that co-incubation with a monoclonal antibody that specifically binds and neutralizes rat group II PLA2 attenuates IL-1 beta and TNF alpha-stimulated PGE2 production by 45% and 52%, respectively. CGP43182, a specific inhibitor of group II PLA2, potently blocks mesangial cell group II PLA2 in vitro with a half-maximal inhibitory concentration (IC50) of 1.5 microM, while only slightly affecting mesangial cell high molecular weight PLA2. CGP 43182 markedly attenuates IL-1 beta- and TNF alpha-stimulated PGE2 synthesis in intact mesangial cells with IC50's of 1.3 and 1.0 microM, respectively. PLA2 secreted from cytokine-stimulated mesangial cells was purified to homogeneity. Addition of the purified enzyme to unstimulated mesangial cells causes a marked release of arachidonic acid and a subsequent increased synthesis of PGE2. Moreover, addition of purified PLA2 to a cloned rat glomerular epithelial cell line and cultured bovine glomerular endothelial cells augmented both arachidonic acid release and PGE2 synthesis, with the endothelial cells being especially sensitive. Thus, cytokine-triggered synthesis and secretion of group II PLA2 by mesangial cells contributes, at least in part, to the observed synthesis of PGE2 that occurs in parallel to the enzyme secretion. Furthermore, extracellular PLA2 secreted by mesangial cells is able to stimulate arachidonic acid release and PGE2 synthesis by the adjacent endothelial and epithelial cells. These data suggest that expression and secretion of group II PLA2 triggered by pro-inflammatory cytokines may crucially participate in the pathogenesis of inflammatory processes within the glomerulus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227364      PMCID: PMC288437          DOI: 10.1172/JCI116860

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  70 in total

Review 1.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

2.  Glucocorticoids inhibit TNF alpha-induced cytosolic phospholipase A2 activity.

Authors:  M Goppelt-Struebe; W Rehfeldt
Journal:  Biochim Biophys Acta       Date:  1992-07-29

3.  Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2.

Authors:  C Schalkwijk; J Pfeilschifter; F Märki; H van den Bosch
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

4.  Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids.

Authors:  D W Coyne; M Nickols; W Bertrand; A R Morrison
Journal:  Am J Physiol       Date:  1992-07

5.  Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process.

Authors:  M Murakami; I Kudo; Y Suwa; K Inoue
Journal:  Eur J Biochem       Date:  1992-10-01

6.  Interleukin-1 alpha stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a non-pancreatic (type II) phospholipase A2.

Authors:  Y Nakazato; M S Simonson; W H Herman; M Konieczkowski; J R Sedor
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

7.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

Authors:  J D Clark; L L Lin; R W Kriz; C S Ramesha; L A Sultzman; A Y Lin; N Milona; J L Knopf
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

8.  Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts.

Authors:  L L Lin; A Y Lin; D L DeWitt
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

9.  Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2.

Authors:  J D Sharp; D L White; X G Chiou; T Goodson; G C Gamboa; D McClure; S Burgett; J Hoskins; P L Skatrud; J R Sportsman
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

10.  Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue.

Authors:  K Takayama; I Kudo; D K Kim; K Nagata; Y Nozawa; K Inoue
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

View more
  41 in total

Review 1.  Antigenic specificities of "antiphospholipid" autoantibodies.

Authors:  R A Roubey
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Potentiation of cytokine induction of group IIA phospholipase A(2) in rat mesangial cells by ATP and adenosine via the A2A adenosine receptor.

Authors:  K Scholz-Pedretti; J Pfeilschifter; M Kaszkin
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP.

Authors:  D Vial; L Arbibe; N Havet; C Dumarey; B Vargaftig; L Touqui
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.

Authors:  C Jacques; G Béréziat; L Humbert; J L Olivier; M T Corvol; J Masliah; F Berenbaum
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

5.  A functional role for eicosanoid-lysophospholipids in activating monocyte signaling.

Authors:  Gao-Yuan Liu; Sung Ho Moon; Christopher M Jenkins; Harold F Sims; Shaoping Guan; Richard W Gross
Journal:  J Biol Chem       Date:  2020-07-08       Impact factor: 5.157

6.  Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.

Authors:  A N Fonteh; J M Samet; F H Chilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

7.  Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation.

Authors:  M H Zou; T Klein; J P Pasquet; V Ullrich
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

8.  Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin.

Authors:  R Cholbi; M L Ferrándiz; M C Terencio; S De Rosa; M J Alcaraz; M Payá
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

9.  Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.

Authors:  Anke Doller; El-Sayed Akool; Andrea Huwiler; Roswitha Müller; Heinfried H Radeke; Josef Pfeilschifter; Wolfgang Eberhardt
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

10.  Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.

Authors:  K S Koumanov; P J Quinn; G Béréziat; C Wolf
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.